Evidence map›Paper›PMID 18687205›Full record

ArticleCurrent infectious disease reports2008

Nodular lymphangitis: a distinctive clinical entity with finite etiologies.

Mark J DiNubile

Abstract read
PubMed Publisher
In one paragraph

Article in Current infectious disease reports, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. CutaneousJAAD case reports · 2022
    Article
  3. Review
  4. Nodular Lymphangitis Syndrome.The American journal of tropical medicine and hygiene · 2017
    Article
  5. Sporothrix schenckii and Sporotrichosis.Clinical microbiology reviews · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Mark J DiNubileMerck Research Laboratories, UG3C-06, PO Box 1000, North Wales, PA 19454, USA. mark_dinubile@merck.com
Merck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nodular lymphangitis, characterized by inflammatory nodules along the lymphatics draining a primary skin infection, most commonly follows superficial inoculation with Sporothrix schenckii, Nocardia brasiliensis, Mycobacterium marinum, Leishmania (Viannia) panamensis/guyanensis, and Francisella tularensis. Epidemiologic context, clinical presentation, and presumed incubation period help to predict the specific etiologic microorganism. Sporotrichosis, often occurring in gardeners, remains the most recognized cause of nodular lymphangitis. Injuries sustained in marine environments suggest Mycobacterium marinum infection. An incubation time of 1 to 5 days, a painful chancre at the initial lesion site, and prominent tender lymphadenitis strongly implicate tularemia. Frankly purulent discharge from the primary lesion is associated with some infections due to Francisella and Nocardia species. Lesions failing to respond to empirical treatment should usually be biopsied. A detailed history and clues from the physical examination, supplemented by biopsy specimens in selected circumstances, should allow specific therapy for most patients.

Identifiers

PMID18687205
OpenAlexW2077226606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.